Background illustration for clinical trials search

ALS Clinical Trials

Browse 127 ALS clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: Providence RI, Lebanon NH, North Massapequa NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06588855

Phase3, Recruiting
Active & Responsive

Multicenter ALS Imaging Study

for
Amyotrophic Lateral Sclerosis, ALS
Location: Gainesville FL, Evanston IL, Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT06735014

Recruiting
Active & Responsive

Healing ALS Registry Observational Study (HAROS)

for
Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND),
Location: Park City UT
Sponsor: Healing Advocates Registry and Ministry

Sex: All

Age: 18 - 70+

Code: NCT07233148

Recruiting
Active & Responsive

Retinal Imaging in Neurodegenerative Disease

for
Alzheimer's Disease, Mild Cognitive Impairment,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT03233646

Recruiting
Active & Responsive

ALS/MND Natural History Study Data Repository

for
ALS, PLS, MND (Motor Neurone DIsease), Kennedy Disease,
Location: Burlington MA, Philadelphia PA, Richmond VA,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05966038

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

for
Frontotemporal Lobar Degeneration (FTLD),
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04363684

Recruiting
Active & Responsive

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

for
Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS),
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT07521930

Recruiting
Active & Responsive

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

for
Amyotrophic Lateral Sclerosis (ALS)
Location: New York NY, Jacksonville FL, Scottsdale AZ,
Sponsor: PhenoNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07142291

Phase2, Recruiting
Active & Responsive

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia

Sex: All

Age: 18 - 70+

Code: NCT07322003

Phase3, Recruiting
Active & Responsive

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

for
Amyotrophic Lateral Sclerosis, Movement Disorders,
Location: Boston MA, New York NY, Georgetown DC, Jacksonville FL,
Sponsor: Target ALS Foundation, Inc.

Sex: All

Age: 18+

Code: NCT05137665

Recruiting

What are ALS clinical trials?

Amyotrophic Lateral Sclerosis (ALS) clinical trials are research studies conducted to explore and evaluate new treatments, therapies, and diagnostic tools for ALS, commonly known as Lou Gehrig’s disease. These trials are crucial in the search for effective ways to slow the progression of the disease, manage symptoms, and ultimately find a cure for ALS.

The importance of clinical trials in ALS research

Clinical trials are essential in ALS research as they are the primary method for testing new treatments and interventions. They help in understanding the effectiveness and safety of these treatments in humans. Through these trials, researchers can uncover new insights into the disease, leading to improved care, symptom management, and potentially life-extending therapies for those affected by ALS.

Types of ALS clinical trials

Innovations in ALS treatment through clinical trials

Who can participate in ALS clinical trials?

How to enroll in an ALS clinical trial